According to the Centers for Disease Control and Prevention (CDC), central line-associated bloodstream infections (CLABSIs) result in thousands of deaths and add billions of dollars of burden to the United States (US) healthcare system each year. CLABSIs have an estimated mortality rate of 12–25% and are thought to be one of the deadliest types of healthcare-associated infections (HAIs). Following catheter-associated urinary tract infections, CLABSIs are estimated to be the second most preventable HAI and have been estimated to be as high as the eighth leading cause of death in the United States. In recent years, the Centers for Medicare and Medicaid Services developed a policy to both deny hospital payments for treatment of hospital-acquired preventable events and potentially impose financially penalties. Through a number of preventative measures, the rate of CLABSI has significantly declined over the past decade, with roughly 18,000 reported occurrences among patients hospitalized in intensive care units (ICUs) in the United States in 2009.
KeywordsCentral line-associated bloodstream infections CLABSI Central lines Catheter-related bloodstream infection CRBSI Catheter
- 1.Center for Disease Control and Prevention. Central Line-associated Bloodstream Infection (CLABSI) 2016 updated 3/1/2016. Available from: https://www.cdc.gov/hai/bsi/bsi.html.
- 2.Center for Disease Control and Prevention. Vital signs: central line-associated blood stream infections--United States, 2001, 2008, and 2009. MMWR Morb Mortal Wkly Rep. 2011;60(8):243–8.Google Scholar
- 6.The Joint Commission. CLABSI Toolkit – Preventing Central-Line Associated Bloodstream Infections: Useful Tools, An International Perspective 2017 updated 2017. Available from: https://www.jointcommission.org/topics/clabsi_toolkit.aspx.
- 12.Lai NM, Lai NA, O’Riordan E, Chaiyakunapruk N, Taylor JE, Tan K. Skin antisepsis for reducing central venous catheter-related infections. Cochrane Database Syst Rev. 2016;(7):Cd010140.Google Scholar
- 13.Gavin NC, Webster J, Chan RJ, Rickard CM. Frequency of dressing changes for central venous access devices on catheter-related infections. Cochrane Database Syst Rev. 2016;(2):Cd009213.Google Scholar
- 14.Lai NM, Chaiyakunapruk N, Lai NA, O’Riordan E, Pau WS, Saint S. Catheter impregnation, coating or bonding for reducing central venous catheter-related infections in adults. Cochrane Database Syst Rev. 2016;(3):Cd007878.Google Scholar
- 15.Ullman AJ, Cooke ML, Mitchell M, Lin F, New K, Long DA, Mihala G, Rickard CM. Dressings and securement devices for central venous catheters (CVC). Cochrane Database Syst Rev. 2015;(9):Cd010367.Google Scholar
- 18.Hidron AI, Edwards JR, Patel J, Horan TC, Sievert DM, Pollock DA, Fridkin SK. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol. 2008;29(11):996–1011.CrossRefGoogle Scholar
- 24.Chatzinikolaou I, Hanna H, Hachem R, Alakech B, Tarrand J, Raad I. Differential quantitative blood cultures for the diagnosis of catheter-related bloodstream infections associated with short- and long-term catheters: a prospective study. Diagn Microbiol Infect Dis. 2004;50(3):167–72.CrossRefGoogle Scholar
- 25.Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O’Grady NP, Raad II, Rijnders BJ, Sherertz RJ, Warren DK. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;49(1):1–45.CrossRefGoogle Scholar